Date of Report (Date of earliest event reported): | |
File No. | |||||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | |||
and Im Langacher, P.O. Box MT-100 CH Greifensee, Switzerland | and 8606 | |||
(Address of principal executive offices) | (Zip Code) | |||
(Former name or former address, if changed since last report.) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | ||
Title of each class | Trading Symbol | Name of each exchange on which registered |
• | It excludes amortization expense. Because this item is recurring, any measure that excludes amortization expense has material limitations. | |
• | It does not include interest expense. Because Mettler-Toledo has borrowed money to finance some of its operations, interest is a necessary and ongoing part of its costs and has assisted Mettler-Toledo in generating revenue. Therefore any measure that excludes interest expense has material limitations. | |
• | It excludes restructuring charges. Because restructuring charges are a component of operating income under U.S. GAAP, any measure that excludes restructuring charges, has material limitations. | |
• | It excludes other charges (income), net. Because other charges (income), net is a component of operating income under U.S. GAAP, any measure that excludes other charges (income), net, has material limitations. | |
• | It includes proceeds from the sale of property, plant and equipment and purchases of property, plant and equipment, which are not considered to be components of net cash provided by operating activities under U.S. GAAP. Therefore any measure that includes proceeds from the sale of property, plant and equipment and purchases of property, plant and equipment has material limitations. | |
• | It excludes restructuring, acquisition cost, Transition Tax payments, and certain other one-time payments which are considered to be components of net cash provided by operating activities under U.S. GAAP. Therefore any measure that excludes these items has material limitations. | |
Exhibit No. | Description | |||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document).* * Submitted electronically with this Report in accordance with the provisions of Regulation S-T. | |||
METTLER-TOLEDO INTERNATIONAL INC. | ||||
Dated: | February 6, 2020 | By: | /s/ Shawn P. Vadala | |
Shawn P. Vadala | ||||
Chief Financial Officer | ||||
FOR IMMEDIATE RELEASE | Exhibit 99.1 | |
• | Reported sales increased 3% compared with the prior year. In local currency, sales increased 4% in the quarter as currency reduced sales growth by 1%. |
• | Net earnings per diluted share as reported (EPS) were $7.84, compared with $7.11 in the prior-year period. Adjusted EPS was $7.78, an increase of 14% over the prior-year amount of $6.85. Adjusted EPS is a non-GAAP measure, and we have included a reconciliation to EPS on the last page of the attached schedules. |
METTLER-TOLEDO INTERNATIONAL INC. CONSOLIDATED STATEMENTS OF OPERATIONS (amounts in thousands except share data) (unaudited) | |||||||||||||||
Three months ended | Three months ended | ||||||||||||||
December 31, 2019 | % of sales | December 31, 2018 | % of sales | ||||||||||||
Net sales | $ | 843,969 | (a) | 100.0 | $ | 817,923 | 100.0 | ||||||||
Cost of sales | 345,672 | 41.0 | 340,357 | 41.6 | |||||||||||
Gross profit | 498,297 | 59.0 | 477,566 | 58.4 | |||||||||||
Research and development | 35,299 | 4.2 | 36,205 | 4.4 | |||||||||||
Selling, general and administrative | 206,717 | 24.5 | 201,653 | 24.7 | |||||||||||
Amortization | 12,813 | 1.5 | 11,963 | 1.5 | |||||||||||
Interest expense | 9,635 | 1.1 | 8,840 | 1.1 | |||||||||||
Restructuring charges | 4,614 | 0.5 | 4,464 | 0.5 | |||||||||||
Other charges (income), net | (1,924 | ) | (0.3 | ) | (16,013 | ) | (c) | (2.0 | ) | ||||||
Earnings before taxes | 231,143 | 27.3 | 230,454 | 28.2 | |||||||||||
Provision for taxes | 38,394 | (b) | 4.5 | 49,268 | (b) | 6.0 | |||||||||
Net earnings | $ | 192,749 | 22.8 | $ | 181,186 | 22.2 | |||||||||
Basic earnings per common share: | |||||||||||||||
Net earnings | $ | 7.95 | $ | 7.25 | |||||||||||
Weighted average number of common shares | 24,241,383 | 249,975,303 | |||||||||||||
Diluted earnings per common share: | |||||||||||||||
Net earnings | $ | 7.84 | $ | 7.11 | |||||||||||
Weighted average number of common and common equivalent shares | 24,599,702 | 25,490,270 | |||||||||||||
Note: | |||||||||||||||
(a) | Local currency sales increased 4% as compared to the same period in 2018. | ||||||||||||||
(b) | Provision for taxes includes a non-cash deferred net benefit of $15.8 million for the three months ended December 31, 2019 related to the enactment of Swiss tax reform and a charge of $3.6 million for the three months ended December 31, 2018 for the enactment of the U.S. Tax Cuts and Jobs Act. | ||||||||||||||
(c) | Other charges (income), net includes a one-time gain of $18.7 million relating to the Biotix acquisition contingent consideration and a one-time legal charge of $3.0 million for the three months ended December 31, 2018. | ||||||||||||||
RECONCILIATION OF EARNINGS BEFORE TAXES TO ADJUSTED OPERATING PROFIT | |||||||||||||||
Three months ended | Three months ended | ||||||||||||||
December 31, 2019 | % of sales | December 31, 2018 | % of sales | ||||||||||||
Earnings before taxes | $ | 231,143 | $ | 230,454 | |||||||||||
Amortization | 12,813 | 11,963 | |||||||||||||
Interest expense | 9,635 | 8,840 | |||||||||||||
Restructuring charges | 4,614 | 4,464 | |||||||||||||
Other charges (income), net | (1,924 | ) | (16,013 | ) | |||||||||||
Adjusted operating profit | $ | 256,281 | (d) | 30.4 | $ | 239,708 | 29.3 | ||||||||
Note: | |||||||||||||||
(d) | Adjusted operating profit increased 7% as compared to the same period in 2018. | ||||||||||||||
METTLER-TOLEDO INTERNATIONAL INC. CONSOLIDATED STATEMENTS OF OPERATIONS (amounts in thousands except share data) (unaudited) | |||||||||||||||
Twelve months ended | Twelve months ended | ||||||||||||||
December 31, 2019 | % of sales | December 31, 2018 | % of sales | ||||||||||||
Net sales | $ | 3,008,652 | (a) | 100.0 | $ | 2,935,586 | 100.0 | ||||||||
Cost of sales | 1,267,441 | 42.1 | 1,251,208 | 42.6 | |||||||||||
Gross profit | 1,741,211 | 57.9 | 1,684,378 | 57.4 | |||||||||||
Research and development | 143,950 | 4.8 | 141,071 | 4.8 | |||||||||||
Selling, general and administrative | 819,183 | 27.2 | 812,802 | 27.7 | |||||||||||
Amortization | 49,690 | 1.7 | 47,524 | 1.6 | |||||||||||
Interest expense | 37,411 | 1.2 | 34,511 | 1.2 | |||||||||||
Restructuring charges | 15,760 | 0.5 | 18,420 | 0.6 | |||||||||||
Other charges (income), net | (6,177 | ) | (0.3 | ) | (21,808 | ) | (c) | (0.7 | ) | ||||||
Earnings before taxes | 681,394 | 22.6 | 651,858 | 22.2 | |||||||||||
Provision for taxes | 120,285 | (b) | 4.0 | 139,247 | (b) | 4.7 | |||||||||
Net earnings | $ | 561,109 | 18.6 | $ | 512,611 | 17.5 | |||||||||
Basic earnings per common share: | |||||||||||||||
Net earnings | $ | 22.84 | $ | 20.33 | |||||||||||
Weighted average number of common shares | 24,567,609 | 25,215,674 | |||||||||||||
Diluted earnings per common share: | |||||||||||||||
Net earnings | $ | 22.47 | $ | 19.88 | |||||||||||
Weighted average number of common and common equivalent shares | 24,974,457 | 25,781,324 | |||||||||||||
Note: | |||||||||||||||
(a) | Local currency sales increased 5% as compared to the same period in 2018. | ||||||||||||||
(b) | Provision for taxes includes a non-cash deferred net benefit of $15.8 million for twelve months ended December 31, 2019 related to the enactment of Swiss tax reform and a charge of $3.6 million for the twelve months ended December 31, 2018 for the enactment of the U.S. Tax Cuts and Jobs Act. | ||||||||||||||
(c) | Other charges (income), net includes a one-time gain of $18.7 million relating to the Biotix acquisition contingent consideration and a one-time legal charge of $3.0 million for the twelve months ended December 31, 2018. | ||||||||||||||
RECONCILIATION OF EARNINGS BEFORE TAXES TO ADJUSTED OPERATING PROFIT | |||||||||||||||
Twelve months ended | Twelve months ended | ||||||||||||||
December 31, 2019 | % of sales | December 31, 2018 | % of sales | ||||||||||||
Earnings before taxes | $ | 681,394 | $ | 651,858 | |||||||||||
Amortization | 49,690 | 47,524 | |||||||||||||
Interest expense | 37,411 | 34,511 | |||||||||||||
Restructuring charges | 15,760 | 18,420 | |||||||||||||
Other charges (income), net | (6,177 | ) | (21,808 | ) | |||||||||||
Adjusted operating profit | $ | 778,078 | (d) | 25.9 | $ | 730,505 | 24.9 | ||||||||
Note: | |||||||||||||||
(d) | Adjusted operating profit increased 7% as compared to the same period in 2018. | ||||||||||||||
METTLER-TOLEDO INTERNATIONAL INC. CONDENSED CONSOLIDATED BALANCE SHEETS (amounts in thousands) (unaudited) | ||||||||
December 31, 2019 | December 31, 2018 | |||||||
Cash and cash equivalents | $ | 207,785 | $ | 178,110 | ||||
Accounts receivable, net | 566,256 | 535,528 | ||||||
Inventories | 274,285 | 268,821 | ||||||
Other current assets and prepaid expenses | 61,321 | 63,401 | ||||||
Total current assets | 1,109,647 | 1,045,860 | ||||||
Property, plant and equipment, net | 748,657 | 717,526 | ||||||
Goodwill and other intangible assets, net | 742,221 | 752,088 | ||||||
Other non-current assets | 188,796 | (a) | 103,373 | |||||
Total assets | $ | 2,789,321 | $ | 2,618,847 | ||||
Short-term borrowings and maturities of long-term debt | $ | 55,868 | $ | 49,670 | ||||
Trade accounts payable | 185,592 | 196,641 | ||||||
Accrued and other current liabilities | 513,052 | (a) | 488,123 | |||||
Total current liabilities | 754,512 | 734,434 | ||||||
Long-term debt | 1,235,350 | 985,021 | ||||||
Other non-current liabilities | 378,679 | (a) | 309,329 | |||||
Total liabilities | 2,368,541 | 2,028,784 | ||||||
Shareholders’ equity | 420,780 | 590,063 | ||||||
Total liabilities and shareholders’ equity | $ | 2,789,321 | $ | 2,618,847 | ||||
(a) | Includes a lease right-of-use asset of $87.3 million, a short-term lease liability of $27.6 million and a long-term lease liability of $60.9 million in accordance with ASC 842 "Leases" that went into effect on January 1, 2019. | |||||||
METTLER-TOLEDO INTERNATIONAL INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (amounts in thousands) (unaudited) | ||||||||||||||||
Three months ended | Twelve months ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2019 | 2018 | 2019 | 2018 | |||||||||||||
Cash flow from operating activities: | ||||||||||||||||
Net earnings | $ | 192,749 | $ | 181,186 | $ | 561,109 | $ | 512,611 | ||||||||
Adjustments to reconcile net earnings to | ||||||||||||||||
net cash provided by operating activities: | ||||||||||||||||
Depreciation | 9,643 | 9,278 | 38,991 | 37,167 | ||||||||||||
Amortization | 12,813 | 11,963 | 49,690 | 47,524 | ||||||||||||
Deferred tax expense | 29,166 | 14,203 | 11,203 | 2,302 | ||||||||||||
Share-based compensation | 5,002 | 5,074 | 18,285 | 17,579 | ||||||||||||
Swiss tax reform benefit (a) | (15,833 | ) | — | (15,833 | ) | — | ||||||||||
U.S. tax reform charge (b) | — | 3,597 | — | 3,597 | ||||||||||||
Acquisition gain (c) | — | (18,674 | ) | — | (18,674 | ) | ||||||||||
Other | 161 | 147 | 133 | (2,559 | ) | |||||||||||
Decrease in cash resulting from changes in | ||||||||||||||||
operating assets and liabilities | (31,992 | ) | (8,202 | ) | (60,128 | ) | (34,542 | ) | ||||||||
Net cash provided by operating activities | 201,709 | 198,572 | 603,450 | 565,005 | ||||||||||||
Cash flows from investing activities: | ||||||||||||||||
Proceeds from sale of property, plant and equipment | 174 | 381 | 1,422 | 8,190 | ||||||||||||
Purchase of property, plant and equipment | (25,714 | ) | (46,061 | ) | (97,341 | ) | (142,726 | ) | ||||||||
Acquisitions | — | (565 | ) | (2,004 | ) | (5,527 | ) | |||||||||
Net hedging settlements on intercompany loans | 2,939 | 1,899 | (1,160 | ) | 1,119 | |||||||||||
Net cash used in investing activities | (22,601 | ) | (44,346 | ) | (99,083 | ) | (138,944 | ) | ||||||||
Cash flows from financing activities: | ||||||||||||||||
Proceeds from borrowings | 627,370 | 168,341 | 1,435,081 | 940,615 | ||||||||||||
Repayments of borrowings | (515,989 | ) | (172,620 | ) | (1,176,784 | ) | (876,324 | ) | ||||||||
Proceeds from exercise of stock options | 9,665 | 9,823 | 47,581 | 24,600 | ||||||||||||
Repurchases of common stock | (216,249 | ) | (118,750 | ) | (774,999 | ) | (474,999 | ) | ||||||||
Acquisition contingent consideration payment | — | — | (10,000 | ) | — | |||||||||||
Other financing activities | — | (250 | ) | 1,753 | (1,914 | ) | ||||||||||
Net cash used in financing activities | (95,203 | ) | (113,456 | ) | (477,368 | ) | (388,022 | ) | ||||||||
Effect of exchange rate changes on cash and cash equivalents | 3,348 | (108 | ) | 2,676 | (8,616 | ) | ||||||||||
Net increase in cash and cash equivalents | 87,253 | 40,662 | 29,675 | 29,423 | ||||||||||||
Cash and cash equivalents: | ||||||||||||||||
Beginning of period | 120,534 | 137,448 | 178,110 | 148,687 | ||||||||||||
End of period | $ | 207,787 | $ | 178,110 | $ | 207,785 | $ | 178,110 | ||||||||
RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO ADJUSTED FREE CASH FLOW | ||||||||||||||||
Net cash provided by operating activities | $ | 201,709 | $ | 198,572 | $ | 603,450 | $ | 565,005 | ||||||||
Payments in respect of restructuring activities | 7,033 | 4,119 | 16,483 | 20,820 | ||||||||||||
Proceeds from sale of property, plant and equipment | 174 | 381 | 1,422 | 8,190 | ||||||||||||
Purchase pf property, plant and equipment | (25,714 | ) | (46,061 | ) | (97,341 | ) | (142,726 | ) | ||||||||
Payments for one-time legal charge (d) | 2,992 | — | 2,992 | — | ||||||||||||
Transition tax payment | — | — | 4,289 | 4,200 | ||||||||||||
Payments for acquisition costs | — | 233 | — | 375 | ||||||||||||
Adjusted free cash flow | $ | 186,194 | $ | 157,244 | $ | 531,295 | $ | 455,864 | ||||||||
(a) | Represents a non-cash deferred net benefit of $15.8 million for the three and twelve months ended December 31, 2019 related to the enactment of Swiss tax reform. | |||||||||||||||
(b) | Represents U.S. tax reform charge of $3.6 million for the three and twelve months ended December 31, 2018 for the implementation of the Tax Cuts and Jobs Act. | |||||||||||||||
(c) | Represents a one-time gain of $18.7 million relating to the Biotix acquisition contingent consideration for the three and twelve months ended December 31, 2018. | |||||||||||||||
(d) | Represents cash payments related to the one-time legal charge recorded during the three months ended December 31, 2018. | |||||||||||||||
METTLER-TOLEDO INTERNATIONAL INC. OTHER OPERATING STATISTICS | ||||||||||||||||||||
SALES GROWTH BY DESTINATION | ||||||||||||||||||||
(unaudited) | ||||||||||||||||||||
Europe | Americas | Asia/RoW | Total | |||||||||||||||||
U.S. Dollar Sales Growth (Decrease) | ||||||||||||||||||||
Three Months Ended December 31, 2019 | (1%) | 6% | 4% | 3% | ||||||||||||||||
Twelve Months Ended December 31, 2019 | (2%) | 5% | 3% | 2% | ||||||||||||||||
Local Currency Sales Growth (Decrease) | ||||||||||||||||||||
Three Months Ended December 31, 2019 | 1% | 6% | 5% | 4% | ||||||||||||||||
Twelve Months Ended December 31, 2019 | 3% | 6% | 6% | 5% | ||||||||||||||||
RECONCILIATION OF DILUTED EPS AS REPORTED TO ADJUSTED DILUTED EPS | ||||||||||||||||||||
(unaudited) | ||||||||||||||||||||
Three months ended | Twelve months ended | |||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||
2019 | 2018 | % Growth | 2019 | 2018 | % Growth | |||||||||||||||
EPS as reported, diluted | $ | 7.84 | $ | 7.11 | 10% | $ | 22.47 | $ | 19.88 | 13% | ||||||||||
Restructuring charges, net of tax | 0.15 | (a) | 0.14 | (a) | 0.50 | (a) | 0.56 | (a) | ||||||||||||
Purchased intangible amortization, net of tax | 0.11 | (b) | 0.10 | (b) | 0.43 | (b) | 0.39 | (b) | ||||||||||||
Income tax expense | 0.32 | (c) | 0.02 | (c) | — | — | ||||||||||||||
Swiss Tax reform | (0.64 | ) | (d) | — | (0.63 | ) | (d) | — | ||||||||||||
U.S. Tax reform | — | 0.14 | (e) | — | 0.14 | (e) | ||||||||||||||
Acquisition gain, net of tax | — | (0.75 | ) | (f) | — | (0.74 | ) | (f) | ||||||||||||
Legal charge, net of tax | — | 0.09 | (g) | — | 0.09 | (g) | ||||||||||||||
Adjusted EPS, diluted | $ | 7.78 | $ | 6.85 | 14% | $ | 22.77 | $ | 20.32 | 12% | ||||||||||
Notes: | ||||||||||||||||||||
(a) | Represents the EPS impact of restructuring charges of $4.6 million ($3.7 million after tax) and $4.5 million ($3.5 million after tax) for the three months ended December 31, 2019 and 2018, and $15.8 million ($12.6 million after tax) and $18.4 million ($14.5 million after tax) for the twelve months ended December 31, 2019 and 2018, respectively, which primarily include employee related costs. | |||||||||||||||||||
(b) | Represents the EPS impact of purchased intangibles amortization, net of tax, of $3.8 million ($2.8 million after tax) and $3.3 million ($2.5 million after tax) for the three months ended December 31, 2019 and 2018, and $14.3 million ($10.8 million after tax) and $13.3 million ($10.0 million after tax) for the twelve months ended December 31, 2019 and 2018, respectively. | |||||||||||||||||||
(c) | Represents the EPS impact of the difference between our reported and annual tax rate before non-recurring discrete items, due to the timing of excess tax benefits associated with stock option exercises. | |||||||||||||||||||
(d) | Represents the EPS impact of a non-cash deferred net benefit of $15.8 million related to the enactment of Swiss tax reform for the three and twelve months ended December 31, 2019. | |||||||||||||||||||
(e) | Represents the EPS impact of U.S. tax reform charges of $3.6 million for the three and twelve months ended December 31, 2018, related to the implementation of the Tax Cuts and Jobs Act. | |||||||||||||||||||
(f) | Represents the EPS impact of a one-time gain of $18.7 million ($19.2 million after tax) for the three and twelve months ended December 31, 2018 associated with the Biotix acquisition contingent consideration. | |||||||||||||||||||
(g) | Represents the EPS impact of a one-time legal charge of $3.0 million ($2.4 million after tax) for the three and twelve months ended December 31, 2018. | |||||||||||||||||||